Pharmaceutical

Gilead and Terray link to develop small-molecule therapies

Gilead Sciences has entered a strategic partnership with Terray for the discovery and development of small-molecule therapies.

Dec 19, 2024 - 06:00
Gilead and Terray link to develop small-molecule therapies
Gilead Sciences has entered a strategic partnership with Terray for the discovery and development of small-molecule therapies.
Read the original article

Tags:

Previous Article

FDA targets more online vendors selling unapproved GLP-1RA products

Next Article

Egyptian Drug Authority approves Lilly and EVA’s insulin injection

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Texas sues Pfizer over ADHD drugs; Merck buys a neuro startup

STAT+: Pharmalittle: Texas sues Pfizer over ADHD drugs;...

Nov 21, 2023

J&J seeks EU approval for new Darzalex multiple myeloma indication

J&J seeks EU approval for new Darzalex multiple myeloma...

Mar 7, 2024

Gilead gains EC approval for metastatic breast cancer drug Trodelvy

Gilead gains EC approval for metastatic breast cancer d...

Jul 29, 2023